Preoperative Management of Myasthenia Gravis
Preoperative Assessment
- The American College of Physicians recommends a comprehensive respiratory assessment with measurements of negative inspiratory force (NIF) and vital capacity (VC) in patients with myasthenia gravis undergoing surgery 1
- The American Academy of Neurology suggests checking acetylcholine receptor (AChR) and muscle-specific tyrosine kinase (MuSK) antibody levels in patients with myasthenia gravis 1, 2
- The American College of Chest Physicians recommends considering a cardiac evaluation with electrocardiogram (ECG) and echocardiogram in patients with respiratory failure or elevated creatine phosphokinase (CPK) levels 1
- The American Academy of Neurology suggests monitoring patients with myasthenia gravis for signs of myasthenic crisis, including respiratory failure, and considering plasma exchange or intravenous immunoglobulin (IVIG) therapy as needed 1
Treatment Recommendations
- The American Academy of Neurology recommends continuing IVIG therapy at a dose of 2 g/kg divided over 5 days (0.4 g/kg/day) in patients with myasthenia gravis undergoing surgery 1, 3, 4
- The American College of Rheumatology suggests considering high-dose corticosteroids, such as methylprednisolone 1-2 mg/kg/day IV or prednisone 1-1.5 mg/kg/day orally, in patients with myasthenia gravis 1
Special Considerations
- The American Academy of Neurology recommends using the "20/30/40" rule to identify patients with myasthenia gravis at risk for respiratory failure: vital capacity <20 mL/kg, maximum inspiratory pressure <30 cm H2O, or maximum expiratory pressure <40 cm H2O 1
Preoperative Management of Myasthenia Gravis Patients Undergoing Thymectomy
Patient Assessment and Preparation
- The National Comprehensive Cancer Network recommends measuring serum antiacetylcholine receptor antibody levels in all patients suspected of having thymomas, even those without symptoms, to avoid respiratory failure during surgery 5
- Patients with dysphagia, notable weight loss, or severe weakness should receive preoperative IVIG, as recommended by the Mayo Clinic 6
IVIG Administration and Monitoring
- The Mayo Clinic recommends checking serum IgA levels before administering IVIG, as IgA deficiency may lead to severe anaphylaxis 6
- Medical control of myasthenia gravis should be achieved before any surgical procedure, according to the National Comprehensive Cancer Network 5
- The American Academy of Ophthalmology suggests continuing anticholinesterase medications (pyridostigmine) perioperatively unless contraindicated 7
Postoperative Care
- Nature Reviews Neurology recommends monitoring closely for signs of myasthenic crisis postoperatively, including respiratory failure, and considering early tracheostomy in high-risk patients 8
- Patients at risk for prolonged mechanical ventilation include those unable to lift arms from bed at 1 week after intubation and those with axonal subtype or unexcitable nerves on electrophysiology, as reported in Nature Reviews Neurology 8
Preoperative Management of Myasthenia Gravis
Patient Selection and Assessment
- Medical control of myasthenia gravis must be achieved before any surgical procedure, according to the National Comprehensive Cancer Network 9
Treatment Recommendations: Plasma Exchange
- The standard protocol for plasma exchange involves 5 sessions of plasma exchange (200-250 mL plasma/kg body weight or 1-L exchanges) performed every other day, 10-30 days before surgery, as recommended by Nature Reviews Neurology 10
- The procedure should exchange twice the blood volume with fresh-frozen plasma or 5% albumin, as suggested by Circulation and Haematologica 11, 12